Company / Operating Margin
TEVA PHARMACEUTICAL INDUSTRIES LTD Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
12.5%
FY2025
5-year range
-14.7% / 12.5%
FY2021-FY2025
Trend
+783.1%
vs FY2024
Sector context
#38 of 135
Health Care
What the data says
Operating Margin changed +783% YoY in FY2025, a notable deviation from the 9-year average annual change of -91%.
Based on SEC 10-K filings.
12.5% in FY2025 with a 5-year CAGR of +33.9%.
Improved from 2.7% to 12.5% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +27.2pp
- 5-Year Change
- +33.9pp
- 10-Year Change
- -
Sector benchmark
#38 of 135 in Health CareTop 28% of 135This company 12.5% Sector average -774.4%
▼
+101.6% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 783.1% year-over-year.
- Currently 786.9pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 12.5% | +783.1% |
| FY2024 | -1.8% | -167.0% |
| FY2023 | 2.7% | +118.5% |
| FY2022 | -14.7% | -236.2% |
| FY2021 | 10.8% | +150.4% |
| FY2020 | -21.4% | -718.3% |
| FY2019 | -2.6% | +70.8% |
| FY2018 | -9.0% | +88.8% |
| FY2017 | -80.0% | -913.6% |
| FY2016 | 9.8% | -42.3% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026